Karthik Radhakrishnan

Affiliations

  • Chief Financial Officer at Monopar Therapeutics (MNPR), 2024-10-30
  • Chief Financial Officer at Opexa Therapeutics Inc. (OPXA), 2015-04-09
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MNPR $16.25 1,550 $25,187.50 1,550 2024-10-28 Filing
OPXA $1.70 8,000 $13,600.00 58,000 2013-12-18 Filing
OPXA $1.50 50,000 $75,000.00 50,000 2013-08-08 Filing